Leaderboards/cancer treatment and pharmacology

cancer treatment and pharmacology

Last updated June 2, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Annemarie Schwab
Friedrich-Alexander-Universität Erlangen-Nürnberg
99
2
Aram Lyu
University of California, San Francisco
80
3
Lawrence Fong
Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa
70
4
Xiaofei Zhi
Nantong University
60
5
Chengfang Zhou
Chongqing Medical University
40
6
Jun Tang
Stanford University
20

Rising Stars Papers

1
Nociceptive neurons promote gastric tumour progression via a CGRP–RAMP1 axis
Nature|2025
92 cit.
2
Nociceptive neurons interact directly with gastric cancer cells via a CGRP/Ramp1 axis to promote tumor progression
bioRxiv (Cold Spring Harbor Laboratory)|2024
3 cit.

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Zong Yao
The University of Western Australia
99
2
Urszula N. Wasko
Columbia University Irving Medical Center
90
3
David Planchard
Harbin Medical University
80
4
Stéphane Ferretti
Novartis (Switzerland)
70
5
Ji Zhou
Changsha Medical University
60
6
Huize Pan
Columbia University Irving Medical Center
50
7
Tohfa Siddiqui
Galgotias University
40
8
Fuming Li
Fudan University
30
9
Liwei Zhao
Inserm
20
10
Deguan Lv
UPMC Hillman Cancer Center
10

Emerging Leaders Papers

1
Mitochondrial dysfunction: mechanisms and advances in therapy
Signal Transduction and Targeted Therapy|2024
923 cit.
2
BCL2 Inhibition Reveals a Dendritic Cell–Specific Immune Checkpoint That Controls Tumor Immunosurveillance
Cancer Discovery|2023
69 cit.
3
Tumor-selective effects of active RAS inhibition in pancreatic ductal adenocarcinoma
bioRxiv (Cold Spring Harbor Laboratory)|2023
11 cit.
4
BET inhibition induces GDH1-dependent glutamine metabolic remodeling and vulnerability in liver cancer
Life Metabolism|2024
5 cit.

All-Time Leaders

The canon

All-Time Leaders Researchers

1
Richard A. Miller
University of Michigan
99
2
Marcus Conrad
Helmholtz Zentrum München
90
3
Steven W. Elmore
AbbVie (United States)
80
4
Fiamma Buttitta
University of Pisa
70
5
Esko A. Nikkilä
Unknown
60
6
Pier Paolo Pandolfi
Memorial Sloan Kettering Cancer Center
50
7
Jean‐Charles Preiser
Université Libre de Bruxelles
40
8
Twan Lammers
Utrecht University
30
9
Alec C. Kimmelman
Harvard University
20
10
Martine Extermann
Moffitt Cancer Center
10

All-Time Leaders Papers

1
FSP1 is a glutathione-independent ferroptosis suppressor
Nature|2019
3.2k cit.
2
Pancreatic cancers require autophagy for tumor growth
Genes & Development|2011
1.5k cit.
3
Tumor targeting via EPR: Strategies to enhance patient responses
Advanced Drug Delivery Reviews|2018
1.2k cit.
4
Smart cancer nanomedicine
Nature Nanotechnology|2019
1.2k cit.
5
Predicting the risk of chemotherapy toxicity in older patients: The Chemotherapy Risk Assessment Scale for High‐Age Patients (CRASH) score
Cancer|2011
1.1k cit.
6
Pten Dose Dictates Cancer Progression in the Prostate
PLoS Biology|2003
667 cit.
7
A non-canonical vitamin K cycle is a potent ferroptosis suppressor
Nature|2022
661 cit.
8
Rapamycin‐mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction
Aging Cell|2013
629 cit.
9
Tumour-targeted nanomedicines: principles and practice
British Journal of Cancer|2008
535 cit.
10
Regulation of lipid peroxidation and ferroptosis in diverse species
Genes & Development|2018
526 cit.

Reagents for cancer treatment and pharmacology

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Recommended

Best all-around

DSHB

Tumor Protein P53 Peptide 2

#CPTC-TP53-2
View Evidence →Cell Signaling Technology

XPB (2C6) Mouse Monoclonal Antibody

#8746$150
View Evidence →Cell Signaling Technology

Cas9 (S. pyogenes) (7A9-3A3) Mouse Monoclonal Antibody (BSA and Azide Free)

#10612$865
View Evidence →

🌟 All-Time

Most validated

Cell Signaling Technology

NETosis Antibody Sampler Kit

Cited in 5 papers
#90144$509
View Evidence →Roche

VENTANA® anti-BRAF V600E (VE1) Mouse Monoclonal Primary Antibody

#760-5095 (also 08033706001)
View Evidence →Agilent/Dako

Progesterone Receptor

#M3569
View Evidence →